|1.||Lillehoj, H S: 3 articles (01/2010 - 10/2001)|
|2.||Palena, Claudia: 3 articles (08/2007 - 11/2003)|
|3.||Schlom, Jeffrey: 3 articles (08/2007 - 11/2003)|
|4.||Huang, Hui: 3 articles (05/2004 - 04/2002)|
|5.||Xiang, Jim: 3 articles (05/2004 - 04/2002)|
|6.||Dorner, Brigitte G: 3 articles (03/2004 - 04/2002)|
|7.||Kroczek, Richard A: 3 articles (03/2004 - 04/2002)|
|8.||Xia, Dajing: 2 articles (04/2011 - 09/2002)|
|9.||Zhang, Lihuang: 2 articles (04/2011 - 09/2002)|
|10.||Wang, Jianli: 2 articles (04/2011 - 09/2002)|
04/01/2011 - "To improve the therapeutic efficacy, we combined with intratumoral injection of adenovirus-mediated lymphotactin (Ad-Lptn) into the overestablished EG7 tumor model. "
11/21/2003 - "These studies suggest a potential role for lymphotactin in the T-cell activation processes and subsequent anti-tumor events."
06/01/2005 - "We have previously demonstrated that adenovirus (AdV)-mediated transgene lymphotactin (Lptn) expression by intratumoral AdVLptn injection and intravenous CD4(+) helper T (Th) cell transfer can enhance Tc-cell tumor infiltration and eradication of early stage tumors (5 mm in diameter). "
06/01/2005 - "Combined CD4+ Th1 effect and lymphotactin transgene expression enhance CD8+ Tc1 tumor localization and therapy."
05/10/2004 - "We have previously demonstrated that adenovirus (AdV)-mediated transgene lymphotactin (Lptn) or IP-10 expression in tumors can significantly enhance T-cell tumor infiltration. "
|2.||Hepatocellular Carcinoma (Hepatoma)
10/01/2004 - "Lymphotactin enhances the in-vitro immune efficacy of dendritoma formed by dendritic cells and mouse hepatocellular carcinoma cells."
11/28/2007 - "To investigate the in-vitro activation of cytotoxic T lymphocytes (CTLs) by fusion of mouse hepatocellular carcinoma (HCC) cells and lymphotactin gene-modified dendritic cells (DCs). "
11/28/2007 - "In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells."
10/01/2004 - "To investigate the in-vitro antitumor immune responses of dendritoma formed by mouse hepatocellular carcinoma (HCC) cells and lymphotactin (Lptn) gene modified dendritic cells (DCs). "
12/01/1991 - "We demonstrate here that primary human hepatocytes and hepatoma cells are able to function as effector cells in the recruitment of inflammatory cells in hepatic disease and inflammatory states by synthesizing a neutrophil/lymphocyte chemotactic factor, interleukin-8. "
11/01/2012 - "Here, we report that the lymphotactin receptor (XCR1) was expressed in primary and metastatic human epithelial ovarian carcinoma (EOC) specimens and cell lines. "
11/01/2012 - "The lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferation."
02/01/2000 - "Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma."
01/01/2008 - "Infection of HD11 cells with mutant SE strains carrying an inactivated type three secretion system (TTSS1 or TTSS2) induced significantly higher levels of CCL4, K203, lymphotactin, and RhoA than wild type SE. "
12/15/2006 - "The dynamics of chicken chemokine expression revealed modest changes (<100-fold) following primary or secondary infection except for lymphotactin. "
01/01/2003 - "It is suggested, therefore, that MG infection of the embryonic membranes causes the embryos to secrete lymphotactin, which induces the migration and accumulation of lymphocytes to the sites of infection."
08/01/2001 - "Lymphotactin: a potential mediator of immunity against Theileria annulata infection of cattle."
03/01/1982 - "A second factor, resembling lymphocyte-derived chemotactic factor, required the addition of SV in vitro, was first detectable at 3 days, reached a peak at 15 to 18 days, and was gone by 29 days after infection. "
|4.||Interleukin-16 (Interleukin 16)
|5.||RNA (Ribonucleic Acid)
|9.||Messenger RNA (mRNA)